stockrowSanofi
SNY Healthcare Drug Manufacturers General
Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.
- Revenue
- +13.9%
- EPS
- +8.21%
- Free cash flow
- +99.6%
- Total debt
- −11.2%
Quarter to September 2026, against a year earlier
Follow SNY
Alert me
Sanofi (SNY) Operating margin
Sanofi's operating margin over the twelve months to 30 September 2026 was 18.7%, up 0.1 percentage points from fiscal 2025 (18.6%). Over the past ten years it has ranged from 14.8% (fiscal 2018) to 38.4% (fiscal 2020); the current reading is higher than 55% of that period. That is in line with the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 18.6% | 1.45 |
| FY2024 | 17.2% | (1.94) |
| FY2023 | 19.1% | (3.33) |
| FY2022 | 22.4% | 1.18 |
| FY2021 | 21.2% | (17.15) |
| FY2020 | 38.4% | 21.14 |
| FY2019 | 17.3% | 2.46 |
| FY2018 | 14.8% | (2.49) |
| FY2017 | 17.3% | (2.49) |
| FY2016 | 19.8% | 1.59 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 28.5% | 11.05 |
| Jun 2026 | 17.5% | (1.07) |
| Mar 2026 | 18.6% | 10.57 |
| Dec 2025 | 7.98% | (20.09) |
| 39 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| AMGN Amgen Inc. compare | 32.4% |
| NVS Novartis AG compare | 25.2% |
| AZN AstraZeneca PLC compare | 23.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| SNY Sanofi | 18.7% |
| GSK GSK PLC Sponsored ADR compare | 18.0% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on SNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement